Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness analysis in oncology.

W K Evans1

  • 1Interdepartmental Program of Oncology, University of Ottawa. bevans@cancercare.on.ca

Praxis
|April 20, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reporting of tobacco use and tobacco-related analyses in cancer cooperative group clinical trials: a systematic scoping review.

ESMO open·2022
Same author

Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada.

Current oncology (Toronto, Ont.)·2020
Same author

Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada.

Current oncology (Toronto, Ont.)·2020
Same author

Smoking Cessation in Cancer Care: Myths, Presumptions and Implications for Practice.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

The generation of two specific cancer costing algorithms using Ontario administrative databases.

Current oncology (Toronto, Ont.)·2019
Same author

Cost-of-illness study for non-small-cell lung cancer using real-world data.

Current oncology (Toronto, Ont.)·2019
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Economic evaluations are crucial for cancer care, guiding choices between effective but costly treatments. Understanding these analyses ensures reliable interpretation for optimal patient value.

Area of Science:

  • Health Economics
  • Oncology
  • Clinical Research

Background:

  • Rising cancer incidence and effective therapies necessitate economic evaluations.
  • An aging population and increasing healthcare costs amplify the need for value-based treatment identification.
  • Economic research operates at macro (population-level cost estimates) and micro (specific strategy cost evaluation) levels.

Purpose of the Study:

  • To review types of economic evaluations in cancer care.
  • To discuss the classification of costs within these evaluations.
  • To highlight key elements and potential biases in economic analyses.

Main Methods:

  • Review of economic evaluation methodologies.
  • Discussion of cost classification (macro vs. micro).

Related Experiment Videos

  • Analysis of critical components: alternatives, perspective, outcomes.
  • Emphasis on transparency and sensitivity analyses for robustness.

    • Main Results:

    • Economic evaluations require careful consideration of alternatives, analytical perspective, and measured outcomes.
    • Potential for bias exists due to numerous variables; transparency and sensitivity analyses are vital for reliable interpretation.
    • Direct comparison of cost-effectiveness across different studies or 'league tables' can be flawed.

    Conclusions:

    • Economic evaluations in oncology are essential for selecting among expensive new treatments.
    • Careful interpretation of individual reports is necessary, considering the specific healthcare context and system.
    • Understanding the nuances of economic analysis ensures appropriate application to clinical decision-making.